Medtronic PLC (MDT) Financials

$92.39

$-1.78 (-1.89%)

As on 08-Sep-2026 16:00EDT

Market cap

$119,166 Mln

Revenue (TTM)

$37,542 Mln

P/E Ratio

24.7

P/B Ratio

2.4

Div. Yield

3.1 %

Income Statement ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Operating Revenue	37,542.00	36,364.00	33,537.00	32,364.00	31,227.00	31,686.00
Cost of Revenue	12,505.00	12,721.00	11,632.00	11,216.00	10,719.00	10,145.00
Gross Profit	25,037.00	23,643.00	21,905.00	21,148.00	20,508.00	21,541.00
Operating Expenses	18,254.00	17,179.00	15,950.00	16,004.00	15,023.00	15,789.00
Operating Profit (EBIT)	6,786.00	6,467.00	5,955.00	5,144.00	5,485.00	5,752.00
Other Income	--	--	--	--	515.00	318.00
Profit before Tax	6,603.00	6,136.00	5,628.00	4,837.00	5,364.00	5,517.00
Provision for Tax	1,333.00	1,299.00	936.00	1,133.00	1,580.00	456.00
Profit after Tax (Net Income)	5,230.00	4,800.00	4,662.00	3,676.00	3,758.00	5,039.00
Minority Interest	-29.00	-37.00	-29.00	-28.00	-26.00	-22.00
Consolidated Profit	2,517.00	--	4,662.00	3,676.00	3,758.00	5,039.00

Liabilities ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Shareholder's Funds	50,232.00	49,463.00	48,024.00	50,214.00	51,483.00	52,551.00
Minority Interest	-29.00	--	--	--	182.00	171.00
Non-Current Liabilities	30,657.00	31,298.00	30,545.00	28,772.00	30,232.00	25,865.00
Current Liabilities	11,799.00	11,658.00	12,879.00	10,789.00	9,051.00	12,394.00
Total Liabilities	105,105.00	93,028.00	91,680.00	89,981.00	90,948.00	90,981.00

Assets ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Non-Current Assets	-503.00	68,240.00	67,865.00	68,046.00	69,274.00	67,920.00
Current Assets	1,777.00	24,787.00	23,814.00	21,935.00	21,675.00	23,059.00
Total Assets	95,083.00	93,028.00	91,680.00	89,981.00	90,948.00	90,981.00
Total Debt*	28,153.00	27,961.00	28,516.00	25,024.00	24,364.00	24,114.00
Net Current Assets	--	13,129.00	10,935.00	11,146.00	12,624.00	10,665.00

Cashflow ($ Mln)	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Cash From Operating Activities	--	7,330.00	7,044.00	6,787.00	6,039.00	7,346.00
Cash Flow from Investing Activities	--	-2,934.00	-1,937.00	-2,366.00	-3,493.00	-1,659.00
Cash from Financing Activities	--	-4,751.00	-4,361.00	-4,450.00	-4,960.00	-5,336.00
Net Cash Inflow / Outflow	--	--	--	--	-2,414.00	351.00

Financials Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
ROCE (%)	--	6.24	6.14	4.87	4.93	6.52
ROE (%)	10.48	9.85	9.49	7.23	7.22	9.69
ROA (%)	5.29	5.20	5.13	4.06	4.13	5.48
EBIT Margin (%)	14.31	18.84	18.96	17.17	19.21	19.16
Net Margin (%)	13.93	13.20	13.90	11.36	11.84	15.74
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Revenue Growth (%)	9.77	0.08	0.04	0.04	-0.01	0.05
EBIT Growth (%)	-16.02	7.77	14.42	-7.40	-1.15	25.93
Net Profit Growth (%)	2.81	2.96	26.82	-2.18	-25.42	39.74
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Price / Earnings	24.70	--	--	--	--	--
Price / Book Value	2.38	--	--	--	--	--
Dividend Yield (%)	3.09	--	--	--	--	--
EV/EBITDA	13.92	1.91	2.12	2.07	1.89	1.54
Close Price ($)	85.39	80.97	84.76	80.24	90.95	104.36
High Price ($)	106.33	106.33	96.25	92.02	106.63	135.89
Low Price ($)	73.32	78.91	75.96	68.84	75.77	98.38
Market Cap ($ Cr)	119,166.21	--	--	--	--	--

Solvency Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Debt to Equity	--	0.57	0.59	0.50	0.47	0.46
Short term debt to equity ratio	0.05	0.04	0.06	0.02	0.00	0.07
Current Ratio	0.15	2.13	1.85	2.03	2.39	1.86
Quick Ratio	0.17	1.62	1.42	1.55	1.81	1.49
Interest Coverage	10.11	9.58	8.72	7.73	9.43	10.98

Operating Efficiency Ratios	TTM	Apr-26	Apr-25	Apr-24	Apr-23	Apr-22
Debtors to sales (%)	0.60	18.27	19.43	18.93	19.21	17.52
Asset Turnover	0.38	0.39	0.37	0.36	0.34	0.34
Receivable days	--	66.08	68.85	68.43	67.54	63.47
Inventory Days	--	164.05	167.88	171.13	168.82	160.74
Payable days	--	73.12	76.29	82.59	84.13	78.88
Cash Conversion Cycle	--	157.01	160.44	156.97	152.24	145.33

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)